Showing results (371-380 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|December 5, 2020
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy ExperienceElie Rassy, Alina Danu, Toni Ibrahim, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 5, 2020
Measurable Residual Disease Assessment and Allogeneic Transplantation as Consolidation Therapy in Adult Acute Lymphoblastic Leukemia in ColombiaJuan Felipe Combariza, Marcos Arango, Laura Díaz, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2020
Extranodal NK/T Cell Lymphoma: Evidence-based Review of Safety and Toxicity of the Available RegimensHayder Saeed, Lubomir Sokol
Clinical Lymphoma, Myeloma & Leukemia|November 2, 2020
Can Next-Generation PI3K Inhibitors Unlock the Full Potential of the Class in Patients With B-Cell Lymphoma?Tycel J Phillips, Jean-Marie Michot, Vincent Ribrag
Clinical Lymphoma, Myeloma & Leukemia|January 22, 2021
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I TrialSwetha Kambhampati, Bita Fakhri, Weiyun Z Ai, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 24, 2021
Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and ChallengesSuvir Singh, Komalpreet Kaur, Davinder Paul, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 9, 2021
Prevalence and Clinical Outcome of FMS-Like Tyrosine Kinase Mutations Among Patients With Core Binding Factor-Acute Myeloid Leukemia: Systematic Review and Meta-AnalysisShyam Srinivasan, Shathish Kumar, Kalasekhar Vijayasekharan, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 9, 2021
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center ExperienceAlexander Ambinder, Matthew Smith, Hua-Ling Tsai, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2021
Secondary Acute Myeloid Leukemia (sAML): Similarly Dismal Outcomes of AML After an Antecedent Hematologic Disorder and Therapy Related AMLChrysavgi Lalayanni, Eleni Gavriilaki, Anastasia Athanasiadou, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple MyelomaGuido Lancman, Katleen Lozada, Nida Athar, et al.
Pageof 251